Compounds > glutamic acid

glutamic acid and ibogaine

glutamic acid has been researched along with ibogaine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scallet, AC; Ye, X1
Elisabetsky, E; Emanuelli, T; Leal, MB; Porciúncula, LD; Souza, DO1
Molliver, ME; O'Hearn, E1
Vastag, B1
Arena, E; Aricò, G; Bertucci, C; Campisi, A; Parenti, C; Pistolozzi, M; Prezzavento, O; Ronsisvalle, G; Ronsisvalle, S; Scoto, GM; Vanella, A1

Reviews

1 review(s) available for glutamic acid and ibogaine

ArticleYear
Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies.
    Annals of the New York Academy of Sciences, 1997, Oct-15, Volume: 825

    Topics: Animals; Brain; Cricetinae; Glutamic Acid; Humans; Hypothalamus; Ibogaine; Kainic Acid; Mice; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Prion Diseases

1997

Other Studies

4 other study(ies) available for glutamic acid and ibogaine

ArticleYear
Ibogaine alters synaptosomal and glial glutamate release and uptake.
    Neuroreport, 2001, Feb-12, Volume: 12, Issue:2

    Topics: Animals; Astrocytes; Calcium; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; Glutamic Acid; Ibogaine; Male; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Synaptosomes; Tetrodotoxin; Tritium; Veratridine

2001
Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.
    Neuroscience, 2004, Volume: 127, Issue:2

    Topics: Animals; Benzodiazepines; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamic Acid; Ibogaine; Male; Nerve Degeneration; Neurotoxins; Olivary Nucleus; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Synapses; Synaptic Transmission; Up-Regulation

2004
Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.
    Science (New York, N.Y.), 2005, Apr-15, Volume: 308, Issue:5720

    Topics: Animals; Brain; Clinical Trials as Topic; Dopamine; Glial Cell Line-Derived Neurotrophic Factor; Glutamic Acid; Hallucinations; Hallucinogens; Humans; Ibogaine; Nerve Growth Factors; Receptors, Nicotinic; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance-Related Disorders

2005
Synthesis and resolution of cis-(+/-)-methyl (1R,2S/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl)cyclopropanecarboxylate [(+/-)-PPCC)]: new sigma receptor ligands with neuroprotective effect.
    Journal of medicinal chemistry, 2010, Aug-12, Volume: 53, Issue:15

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Astrocytes; Cells, Cultured; Cyclopropanes; Drug Interactions; Glutamic Acid; Glutathione; GTP-Binding Proteins; Ibogaine; Ligands; Neuroprotective Agents; Oxidative Stress; Pentazocine; Piperidines; Protein Glutamine gamma Glutamyltransferase 2; Rats; Reactive Oxygen Species; Receptors, Opioid, kappa; Receptors, sigma; Stereoisomerism; Structure-Activity Relationship; Transglutaminases

2010